Vestmark Advisory Solutions, Inc. Novartis Ag Transaction History

Vestmark Advisory Solutions, Inc.

$2.63 Billion
Q4 2024

A detailed history of Vestmark Advisory Solutions, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Vestmark Advisory Solutions, Inc. holds 8,564 shares of NVS stock, worth $902,902. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,564

Previous 8,499 0.76%

Holding current value

$902,902

Previous $977,000 14.74%

% of portfolio

0.03%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	BUY	$96.78 - $117.18 $6,290 - $7,616	65 Added 0.76%	8,564 $833,000
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $361,054 - $411,267	-3,402 Reduced 28.59%	8,499 $977,000
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $389,812 - $452,135	-4,211 Reduced 26.14%	11,901 $1.27 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $71,833 - $81,786	-754 Reduced 4.47%	16,112 $1.56 Million
Q4 2023 Feb 06, 2024	BUY	$92.27 - $101.54 $218,310 - $240,243	2,366 Added 16.32%	16,866 $1.7 Million
Q3 2023 Nov 06, 2023	SELL	$94.73 - $105.13 $3.03 Million - $3.36 Million	-31,950 Reduced 68.78%	14,500 $1.48 Million
Q2 2023 Aug 07, 2023	SELL	$92.52 - $104.91 $308,184 - $349,455	-3,331 Reduced 6.69%	46,450 $4.69 Million
Q1 2023 May 09, 2023	BUY	$80.03 - $92.81 $7,682 - $8,909	96 Added 0.19%	49,781 $4.58 Million
Q4 2022 Jan 20, 2023	SELL	$75.55 - $92.52 $37,019 - $45,334	-490 Reduced 0.98%	49,685 $0
Q3 2022 Nov 03, 2022	BUY	$74.61 - $87.26 $1.13 Million - $1.32 Million	15,117 Added 43.12%	50,175 $3.81 Million
Q2 2022 Aug 04, 2022	SELL	$80.52 - $93.75 $134,951 - $157,125	-1,676 Reduced 4.56%	35,058 $2.96 Million
Q1 2022 Apr 27, 2022	BUY	$80.11 - $90.62 $445,251 - $503,665	5,558 Added 17.83%	36,734 $3.22 Million
Q4 2021 Jan 31, 2022	BUY	$79.7 - $88.13 $100,501 - $111,131	1,261 Added 4.22%	31,176 $2.73 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $159,307 - $185,332	1,948 Added 6.97%	29,915 $2.45 Million
Q2 2021 Aug 09, 2021	BUY	$85.24 - $94.15 $237,137 - $261,925	2,782 Added 11.05%	27,967 $2.55 Million
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $215,096 - $253,658	-2,576 Reduced 9.28%	25,185 $2.15 Million
Q4 2020 Feb 04, 2021	SELL	$78.07 - $94.43 $426,886 - $516,343	-5,468 Reduced 16.46%	27,761 $2.62 Million
Q3 2020 Oct 19, 2020	SELL	$82.14 - $91.0 $55,444 - $61,425	-675 Reduced 1.99%	33,229 $2.89 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $24,764 - $27,876	-306 Reduced 0.89%	33,904 $2.96 Million
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $9,187 - $12,871	-130 Reduced 0.38%	34,210 $2.82 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $236,348 - $267,226	2,802 Added 8.88%	34,340 $3.25 Million
Q3 2019 Nov 05, 2019	BUY	$85.54 - $94.26 $203,243 - $223,961	2,376 Added 8.15%	31,538 $2.74 Million
Q2 2019 Aug 20, 2019	BUY	$75.4 - $92.8 $173,797 - $213,904	2,305 Added 8.58%	29,162 $2.66 Million
Q1 2019 May 14, 2019	BUY	$75.32 - $86.15 $2.02 Million - $2.31 Million	26,857 New	26,857 $2.58 Million

Others Institutions Holding NVS

# of Institutions

1,462

Shares Held

132M

Call Options Held

1.33M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestmark Advisory Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vestmark Advisory Solutions, Inc. with notifications on news.

Account

Vestmark Advisory Solutions, Inc. Novartis Ag Transaction History